Congestive Heart Failure
Congestive heart failure (CHF) means the heart can’t pump enough blood to meet the needs of the body. It worsens over time. CHF causes breathing problems, swelling in the legs, and lack of strength. There are different possible causes. The most common is a problem with blood flow to the heart.
CHF is treated with habit changes and drugs. Surgery may be needed to help the heart work better and control fluid buildup. Some people may need a new heart from a donor.
CHF should not be self-treated. Work closely with your care team. Some natural therapies may be a part of your treatment plan to ease symptoms.
Herbs and supplements:
May or May Not Be Effective
Editorial process and description of evidence categories can be found at EBSCO NAT Editorial Process.
Herbs and Supplements to Be Used With Caution
Talk to your doctor about all herbs or pills you are taking. Some may get in the way of your treatment or health problems, such as:
References[ + ]
A1. Tauchert M. Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patstrength chronic stable New York Heart Association class-III heart failure. Am Heart J. 2002;143:910-915.
A2. Pittler MH, Schmidt K, Ernst E. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials. Am J Med. 2003;114:665-74.
A3. Zick SM, Gillespie B, Aaronson KD. The effect of Crataegus oxycantha special extract WS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure. Eur J Heart Fail. 2008 May 17.
A4. Holubarsch CJ, Colucci WS, et al. The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial. Eur J Heart Fail. 2008 Dec;10(12):1255-1263.
A5. Pittler M, Guo R, Ernst E. Hawthorn extract for treating chronic heart failure. Cochrane Database Syst Rev.2008;CD005312.
A6. Li X, Zhang J, et al. A multicenter, randomized, double-blind parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure. J Am Coll Cardiol. 2013 Sep 17;62(12):1065-1072.
A7. Zhou Q, Qin WZ, et al. Shengmai (a traditional Chinese herbal medicine) for heart failure. Cochrane Database Syst Rev. 2014 Apr 14;(4):CD005052.
A8. Zhu YS, Li YL, Ju JQ, Du F, Zang YP, Wang XB, Sheng J. Oral Chinese Herbal Medicine for Treatment of Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2016;2016:1819794.
B1. Study on propionyl-L-carnitine in chronic heart failure. Eur Heart J. 1999 Jan;20(1):70-6.
refB2 Rizos I. Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration. Am Heart J. 2000 Feb;139(2 Pt3):S120-3.
B3. Tavazzi L, Maggioni AP, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008 Oct 4;372(9645):1223-12230.
B4. Witham MD, Crighton LJ, Gillespie ND, Struthers AD, McMurdo ME. The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ Heart Fail. 2010 Mar;3(2):195-201.
B5. Cornelissen VA, Defoor JG, et al. Effect of creatine supplementation as a potential adjuvant therapy to exercise training in cardiac patients: a randomized controlled trial. Clin Rehabil. 2010 Nov;24(11):988-999.
B6. Horjus DL, Oudman I, van Montfrans GA, Brewster LM. Creatine and creatine analogues in hypertension and cardiovascular disease. Cochrane Database Syst Rev. 2011 Nov 9;11:CD005184.
B7. Xin W, Wei W, et al. Effects of fish oil on supplementation on cardiac function in chronic heart failure: a meta-analysis of randomised controlled trials. Heart. 2012 Nov;98(22):1620-1650.
B8. Madmani ME, Solaiman AY, et al. Coenzyme Q10 for heart failure. Cochrane Database Syst Rev. 2013;CD008684.
B9. Fotino AD, Thompson-Paul AM, et al. Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis. Am J Clin Nutr. 2013 Feb;97(2):268-275.
B10. Boxer RS, Kenny AM, Schmotzer BJ, Vest M, Fiutem JJ, Piña IL. A randomized controlled trial of high dose vitamin D3 in patients with heart failure. JACC Heart Fail. 2013 Feb;1(1):84-90.
B11. Mortensen SA, Rosenfeldt F, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014 Dec;2(6):641-649.
C1. Barrow DE, Bedford A, Ives G, O'Toole L, Channer KS. An evaluation of the effects of Tai Chi Chuan and Chi Kung training in patients with symptomatic heart failure: a randomised controlled pilot study. Postgrad Med J. 2007;83(985):717-721.
C2. Yeh GY, Wayne PM, Phillips RS. Tai Chi exercise in patients with chronic heart failure. Med Sport Sci. 2008;52:195-208.
C3. Yeh GY, McCarthy EP, Wayne PM, Stevenson LW, Wood MJ, Forman D, Davis RB, Phillips RS. Tai chi exercise in patients with chronic heart failure: a randomized clinical trial. Arch Intern Med. 2011 Apr 25;171(8):750-7.
Last reviewed March 2019 by EBSCO NAT Review Board Richard Glickman-Simon, MD
Last Updated: 3/2/2019
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.